Programme

-

The Future of Sustainability

Speakers

Al Gore
Former Vice President of the United States | Chairman of Generation Investment Management
Rachel Teo
Head of Futures (Research) Unit, and Senior Vice President, Economics & Investment Strategy | GIC

Sustainable investing has been on the rise in recent years, compelled by stronger evidence and greater awareness. It has become increasingly clear that sustainability issues like climate change have a material impact on investment returns. However, the perfect translation of theory to action remains elusive. What are the most compelling investment risks and opportunities in themes like climate change? What roles should the public and private sectors play in driving positive outcomes? How has the COVID-19 pandemic affected the development of ‘Sustainable Finance’? What does the future of mainstream sustainable investing look like?

-

The Future of Sustainability – In Practice

Speakers

Jeremy Grantham
Co-Founder | GMO
Bob Litterman
Chairman of the Risk Committee | Kepos Capital
Debbie McCoy
Head of Sustainable Investing, BlackRock Systematic Division | BlackRock
Jaap van Dam
Principal Director Investment Strategy | PGGM
Liew Tzu Mi
Chief Investment Officer, Fixed Income | GIC

While the growing focus on sustainability offers new opportunities for long-term investors, portfolio exposure to sustainability risks and disruption also need to be carefully managed. In this session, we will explore how long-term investors are integrating sustainability considerations into their investment frameworks, strategies and processes, the challenges faced, and how these can be overcome.

-

The Future of Biopharma Supply Chains

Speakers

Marc Casper
Chairman, President & CEO | Thermo Fisher Scientific
Chris Chen
CEO | WuXi Biologics
Erez Israeli
CEO | Dr. Reddy's
Doreen Chia
Managing Director, Public Equities, and Co-Chair of Healthcare Business Group | GIC

Due to COVID-19, various countries imposed limits or bans on some medical supply exports. In response, the US recently passed the ‘Mitigating Emergency Drug Shortages Act’ to better track drug supplies and assess national security risks and is considering tightening laws to force federal agencies to buy locally-made pharmaceutical and medical equipment. Low labour costs, state subsidies and easier regulations helped make markets like China and India attractive as manufacturing hubs; reversing this trend will not be easy. What is the outlook for supply chain onshoring, drugs’ costs and pricing dynamics, and the potential winners and losers in post-pandemic world?

-

The Future of Tech-enabled Healthcare

Speakers

Todd Park
Co-Founder & Executive Chairman | Devoted Health
David Simmons
Chairman & CEO | PPD
John Cai
Vice Chairman & Group President | WeDoctor
Brad Yale
Senior Vice President, Private Equity, and Co-Chair of Healthcare Business Group | GIC

The pandemic is putting our healthcare system to the test. Healthcare leaders, stakeholders, and frontline responders are rising to the challenge and accelerating tech-enabled care delivery and clinical development. At this session, our panel will share their perspectives on how these innovative efforts are shaping global healthcare for the future.

-

The Future of Communications

Speakers

Eric Yuan
Founder & CEO | Zoom
Ethel Chen
Senior Vice President, Technology Investment Group | GIC

At this session, Eric Yuan, Founder and CEO of Zoom, the world’s leading web-conferencing platform, will share his views on how people and businesses will adapt their communications needs in a post-COVID world. As the digital communications landscape evolves, what are the gaps and opportunities ahead?